PMID: 6986415Jan 1, 1980Paper

Cutaneous infections and disorders of inflammation

Journal of the American Academy of Dermatology
M E Miller

Abstract

In 1908, the Nobel Prize in Physiology and Medicine was shared by Elie Metchnikoff and Paul Ehrlich. Their joint commendation acknowledged the vigorous debate which then existed and, in a sense, paved the way for our modern recognition that both cellular and humoral mechanisms might participate in immunity. Of Ehrlich's and Metchnikoff's many accomplishments, those concerning the basic nature of the inflammatory reaction suggested a clinical potential that has been realized only in the last decade. Central to their theories was the implication that normal inflammatory processes were of benefit to the host and that disordered inflammation was likely to lead to disease. Over the past decade or so, we have recognized an extensive set of diseases associated with primary or acquired deficiencies of inflammation, thus beginning to catch up to the genius of Ehrlich and Metchnikoff. Most, if not all, of these disorders demonstrate major cutaneous involvement in their clinical and biologic presentations. It is thus of essential importance that the dermatologist be familiar with this fascinating spectrum of disease, and it is to this end that this review is directed.

References

Dec 1, 1979·Clinical Immunology and Immunopathology·M E Miller
Jan 1, 1979·Annals of the New York Academy of Sciences·B H Waksman
Feb 1, 1977·The Journal of Pediatrics·R B Johnston, R M Stroud
Jan 1, 1976·Immunological Communications·P M Henson
Feb 11, 1975·British Journal of Haematology·W L MarshF H Allen
Feb 26, 1976·The New England Journal of Medicine·J G SissonsD K Peters
Mar 30, 1972·The New England Journal of Medicine·B MoncadaD B Windhorst
Sep 26, 1974·The New England Journal of Medicine·K F Austen
Apr 25, 1969·Science·R E SpitzerC D West
Jun 1, 1969·Archives of Dermatology·D L TuffanelliK Fukuyama
Jul 1, 1971·The Journal of Experimental Medicine·L EllmanM M Frank
Sep 1, 1968·Biochemistry·B A Bray, K Laki
May 2, 1968·The New England Journal of Medicine·R L Baehner, D G Nathan
Jan 1, 1971·British Journal of Pharmacology·P Crunkhorn, A L Willis
Feb 1, 1974·The Journal of Experimental Medicine·P DukorD Bitter-Suermann
Nov 21, 1974·The New England Journal of Medicine·L A BoxerT P Stossel
Dec 13, 1972·Nature: New Biology·S H Ferreira
Mar 22, 1973·The New England Journal of Medicine·C A AlperF S Rosen
Dec 1, 1973·The Journal of Experimental Medicine·K D Wuepper
Jan 1, 1971·Annual Review of Medicine·D L Wilhelm
Jan 1, 1971·The Journal of Pediatrics·R J PickeringH Gewurz
Jul 1, 1971·The Journal of Experimental Medicine·M M FrankL Ellman
Mar 1, 1970·Neurology·S M Chou, L Gutmann
Dec 1, 1970·Journal of the Neurological Sciences·F L Mastaglia, J N Walton
Feb 1, 1974·The Journal of Clinical Investigation·E J Goetzl, K F Austen
Feb 3, 1962·Nature·J BROOME, R K ARCHER
Jun 1, 1963·Nature·R K ARCHER, J BROOME
Sep 1, 1962·The Journal of Experimental Medicine·G B MACKANESS

❮ Previous
Next ❯

Citations

Jan 24, 2006·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·M O MurphyM G Walker
Dec 1, 1988·Experientia·C Canicattí
Oct 1, 1986·Agents and Actions·J Westwick, C Poll
Nov 10, 2020·Dermatologic Therapy·Swetha Y Sanghvi, Robert A Schwartz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.